Altimmune COVID-19 Response

Click here to read about AdCOVIDTM Intranasal COVID-19 Vaccine and T-COVIDTM Intranasal Therapeutic for COVID-19 infection

Click here if you are interested in enrolling in our T-COVID EPIC Clinical Study

OUR PIPELINE

Our diverse pipeline includes treatments for NASH (ALT-801), chronic Hepatitis B (HepTcell™), and conjugated immunostimulants for the treatment of cancer (ALT-702). In addition, we are developing intranasal vaccine & therapeutic candidates for anthrax, influenza and COVID-19.

LIVER THERAPIES

CANCER

INTRANASAL VACCINES & THERAPEUTICS